Protein E7 (43-62)
Protein E7 (43-62) is an E7-derived peptide with anti-tumor effects (short peptide spanning the 43th to 62th amino acid residues in the E7 protein) [1].
Product Specifications
CAS Number
143853-58-1
UNSPSC
12352209
Target
HPV
Type
Peptides
Related Pathways
Anti-infection
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/protein-e7-43-62.html
Solubility
10 mM in DMSO
Smiles
NCC(N[C@@H](CCC(N)=O)C(N[C@@H](C)C(N[C@@H](CCC(O)=O)C(N1[C@@H](CCC1)C(N[C@@H](CC(O)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C)C(N[C@H](C(N[C@H](C(N[C@@H](CC(N)=O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](C(C)C)C(N[C@@H]([C@H](O)C)C(N[C@H](C(N[C@@H](CS)C(N[C@@H](CS)C(N[C@@H](CCCCN)C(N[C@@H](CS)C(N[C@H](C(O)=O)CC(O)=O)=O)=O)=O)=O)=O)CC2=CC=CC=C2)=O)=O)=O)=O)=O)CC3=CC=C(C=C3)O)=O)CC4=CN=CN4)=O)=O)=O)=O)=O)=O)=O)=O
Molecular Formula
C95H144N28O31S3
Molecular Weight
2270.52
References & Citations
[1]Min Luo, et al. A STING-activating Nanovaccine for Cancer Immunotherapy. Nat Nanotechnol. 2017 Jul;12 (7) :648-654.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
033430-Biotin 200 µL
CCR4, CT (CCR4, CMKBR4, C-C chemokine receptor type 4, K5-5, CD194) (Biotin) discontinued
Sign In for Pricing
View Details 
G3500-30-ML550 100 µL
GluR5 (Glutamate Receptor) (MaxLight 550) discontinued
Sign In for Pricing
View Details 
A01070-2-Fluoro594 100 µg/Vial
Anti-nNOS (neuronal) /NOS1 Antibody Picoband® Fluoro594 Conjugated
Sign In for Pricing
View Details